The Food and Drug Administration (FDA) today released the long-awaited proposed regulations for the over-the-counter (OTC) hearing aids.
The Federal Register notice this morning includes the pre-publication release of the proposed rule, “Medical Devices: Ear, Nose, and Throat Devices; Establishing Over-the-Counter Hearing Aids,” for public inspection and notes that the FDA will accept comments for the next 90 days. The FDA issued a press release about the proposed rule of the new OTC category for adults age 18 and older with perceived mild to moderate hearing loss.
The FDA also released today updated draft guidance about the intended uses, regulatory requirements, and differences between hearing aids and personal sound amplification products (PSAPs). The guidance document, “Regulatory Requirements for Hearing Aid Devices and Personal Sound Amplification,“ is also available for public review and comment.
The Academy has established a subject matter expert (SME) work group to review the proposed rule and new guidance. The work group will prepare comments for board review, and the Academy will submit comments to the FDA on behalf of the organization.
The Academy will keep you further informed on these rules and implications for the profession.
Related Posts
Academy Recommends Changes to Proposed Amendments to New York EHDI Screening Protocol
The New York Department of Health recently proposed shifting to a two-tiered testing protocol in the New York Universal Newborn Hearing Screening Programs (UNHS) to “be consistent with nationally recognized standards established by the Joint Committee of Infant Hearing (JCIH).” The New York proposal would mandate utilizing an otoacoustic emissions (OAE) screening followed by an…
Biden Administration Takes Action to Advance Responsible Artificial Intelligence, Research, Development, and Deployment
On May 23, the Biden Administration released FACT SHEET: Biden-Harris Administration Takes New Steps to Advance Responsible Artificial Intelligence Research, Development, and Deployment | The White House, outlining the myriad of actions taken to date to identify and manage the risks of artificial intelligence (AI) including a Blueprint for an AI Bill of Rights |…
HHS-OIG Releases Toolkit for Assessing Telehealth Billing Risks
Released last week by the U.S. Department of Health and Human Services (HHS) Office of the Inspector General (OIG), a new federal toolkit aims to help health-care stakeholders analyze their telehealth claims data to assess program integrity risks. The toolkit is based on the methodology developed for a report published September 2022 that assessed providers who billed Medicare for…